GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human CHK2 in complex with benzimidazole carboxamide inhibitor

Analyse Crystal structure of human CHK2 in complex with benzimidazole carboxamide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4A9R
Type
protein
Length
285 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
RU5, NO3
Pockets
3 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28542% helix, 16% strandO96017

Ligands and binding sites

  • RU5 · 2-[4-(4-chlorophenoxy)phenyl]-1H-benzimidazole-6-carboxamide · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11990.540.7827RU5
21050.350.7422empty
31010.350.7320empty

Compared structures

  • 4A9R · Crystal structure of human CHK2 in complex with benzimidazole carboxamide inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.